Analysts Predict Aclaris Therapeutics Inc (NASDAQ:ACRS) To Reach 25 In 12 Months
In last trading session, Aclaris Therapeutics Inc (NASDAQ:ACRS) saw 0.42 million shares changing hands with its beta currently measuring 0.28. Company’s recent per share price